A Dutch investment company was considering a project to produce feed-grade lysine in Russia for export. When Argus joined the project, a team of scientists and process specialists was already in place, the production technology had been validated in the laboratory, and a business plan had been prepared. The project team had also discussed the proposed site with local authorities.
The investor was prepared to fund the project provided the team met agreed development criteria. The immediate question was whether the business plan and available R&D resources could support the transition from laboratory validation to pilot production.